Patents Assigned to Novita Pharmaceuticals, Inc.
  • COMPOUNDS AND METHODS FOR INHIBITING FASCIN
    Publication number: 20240124449
    Abstract: Provided are compounds, compositions and methods for inhibiting fascin activity or treating a condition or disorder mediated by fascin activity in a subject in need thereof.
    Type: Application
    Filed: December 21, 2023
    Publication date: April 18, 2024
    Applicants: NOVITA PHARMACEUTICALS, INC., CORNELL UNIVERSITY
    Inventors: Xin-Yun Huang, Christy Young Shue
  • Methods for inhibiting fascin
    Patent number: 11866440
    Abstract: Provided are compositions and methods for treating a condition or disorder mediated by fascin activity in a subject in need thereof which method comprises administering to the subject a therapeutically effective amount of at least one compound of any one of Formula I-a to I-n, II, II-a, II-b or III or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: January 28, 2021
    Date of Patent: January 9, 2024
    Assignees: CORNELL UNIVERSITY, NOVITA PHARMACEUTICALS, INC.
    Inventors: Xin-Yun Huang, Christy Young Shue
  • Compounds and methods for inhibiting fascin
    Patent number: 11858929
    Abstract: Provided are compounds, compositions and methods for inhibiting fascin activity or treating a condition or disorder mediated by fascin activity in a subject in need thereof.
    Type: Grant
    Filed: February 16, 2021
    Date of Patent: January 2, 2024
    Assignees: CORNELL UNIVERSITY, NOVITA PHARMACEUTICALS, INC.
    Inventors: Xin-Yun Huang, Christy Young Shue
  • CO-THERAPIES INCLUDING A METASTASIS INHIBITOR
    Publication number: 20230310378
    Abstract: Provided are methods of increasing a response to a chemotherapeutic agent or an immunotherapeutic agent in a patient in need thereof, and methods of treating cancer in a patient in need thereof, comprising administering to the patient a chemotherapeutic agent or an immunotherapeutic agent and a metastasis inhibiting compound, as described in this disclosure.
    Type: Application
    Filed: May 23, 2023
    Publication date: October 5, 2023
    Applicants: NOVITA PHARMACEUTICALS, INC., CORNELL UNIVERSITY
    Inventors: Xin-Yun HUANG, Jue Jillian ZHANG, Christy Young Shue
  • Co-therapies including a metastasis inhibitor
    Patent number: 11701342
    Abstract: Provided are methods of increasing a response to a chemotherapeutic agent or an immunotherapeutic agent in a patient in need thereof, and methods of treating cancer in a patient in need thereof, comprising administering to the patient a chemotherapeutic agent or an immunotherapeutic agent and a metastasis inhibiting compound, as described in this disclosure.
    Type: Grant
    Filed: November 20, 2018
    Date of Patent: July 18, 2023
    Assignees: CORNELL UNIVERSITY, NOVITA PHARMACEUTICALS, INC.
    Inventors: Xin-Yun Huang, Jue Jillian Zhang, Christy Young Shue
  • Methods for inhibiting fascin
    Patent number: 10941146
    Abstract: Provided are compositions and methods for treating a condition or disorder mediated by fascin activity in a subject in need thereof which method comprises administering to the subject a therapeutically effective amount of at least one compound of any one of Formula I-a to I-n, II, II-a, II-b or III or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: February 15, 2019
    Date of Patent: March 9, 2021
    Assignees: NOVITA PHARMACEUTICALS, INC., CORNELL UNIVERSITY
    Inventors: Xin-Yun Huang, Christy Young Shue
  • Compounds and methods for inhibiting fascin
    Patent number: 10941141
    Abstract: Provided are compounds, compositions and methods for inhibiting fascin activity or treating a condition or disorder mediated by fascin activity in a subject in need thereof.
    Type: Grant
    Filed: March 11, 2019
    Date of Patent: March 9, 2021
    Assignees: NOVITA PHARMACEUTICALS, INC., CORNELL UNIVERSITY
    Inventors: Xin-Yun Huang, Christy Young Shue
  • Compounds and methods for inhibiting fascin
    Patent number: 10227345
    Abstract: Provided are compounds, compositions and methods for inhibiting fascin activity or treating a condition or disorder mediated by fascin activity in a subject in need thereof.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: March 12, 2019
    Assignees: Cornell University, Novita Pharmaceuticals, Inc.
    Inventors: Xin-Yun Huang, Christy Young Shue
  • Methods for inhibiting fascin
    Patent number: 10208043
    Abstract: Provided are compositions and methods for treating a condition or disorder mediated by fascin activity in a subject in need thereof which method comprises administering to the subject a therapeutically effective amount of at least one compound of any one of Formula I-a to I-n, II, II-a, II-b or III or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 21, 2013
    Date of Patent: February 19, 2019
    Assignees: Cornell University, Novita Pharmaceuticals, Inc.
    Inventors: Xin-Yun Huang, Christy Young Shue
  • Compounds and methods for inhibiting fascin
    Patent number: 9850243
    Abstract: Provided are compounds, compositions and methods for inhibiting fascin activity or treating a condition or disorder mediated by fascin activity in a subject in need thereof.
    Type: Grant
    Filed: February 20, 2017
    Date of Patent: December 26, 2017
    Assignees: NOVITA PHARMACEUTICALS, INC., CORNELL UNIVERSITY
    Inventors: Xin-Yun Huang, Christy Young Shue
  • Compounds and methods for inhibiting fascin
    Patent number: 9573946
    Abstract: Provided are compounds, compositions and methods for inhibiting fascin activity or treating a condition or disorder mediated by fascin activity in a subject in need thereof.
    Type: Grant
    Filed: February 19, 2015
    Date of Patent: February 21, 2017
    Assignees: Novita Pharmaceuticals, Inc., Cornell University
    Inventors: Xin-Yun Huang, Christy Young Shue